Sensus Healthcare Inc. (SRTS)
NASDAQ: SRTS
· Real-Time Price · USD
4.33
0.03 (0.70%)
At close: May 01, 2025, 3:59 PM
4.33
0.00%
After-hours: May 01, 2025, 04:05 PM EDT
0.70% (1D)
Bid | 4.27 |
Market Cap | 71.43M |
Revenue (ttm) | 41.81M |
Net Income (ttm) | 6.65M |
EPS (ttm) | 0.41 |
PE Ratio (ttm) | 10.56 |
Forward PE | 7.14 |
Analyst | Buy |
Ask | 4.71 |
Volume | 79,475 |
Avg. Volume (20D) | 260,681 |
Open | 4.29 |
Previous Close | 4.30 |
Day's Range | 4.28 - 4.41 |
52-Week Range | 3.48 - 9.33 |
Beta | 1.11 |
About SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and s...
Industry Medical - Devices
Sector Healthcare
IPO Date Jul 26, 2016
Employees 54
Stock Exchange NASDAQ
Ticker Symbol SRTS
Website https://www.sensushealthcare.com
Analyst Forecast
According to 3 analyst ratings, the average rating for SRTS stock is "Buy." The 12-month stock price forecast is $13, which is an increase of 200.23% from the latest price.
Stock ForecastsNext Earnings Release
Sensus Healthcare Inc. is scheduled to release its earnings on May 15, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-32.37%
Sensus Healthcare shares are trading lower after t...
Unlock content with
Pro Subscription
2 months ago
+6.52%
Sensus Healthcare shares are trading lower after the company reported mixed Q4 financial results.